ATE479778T1 - Verfahren zur diagnose nicht-kleinzelliger lungenkarzinome über die trna-dihydrouridin- synthaseaktivität von urlc8 - Google Patents
Verfahren zur diagnose nicht-kleinzelliger lungenkarzinome über die trna-dihydrouridin- synthaseaktivität von urlc8Info
- Publication number
- ATE479778T1 ATE479778T1 AT05788285T AT05788285T ATE479778T1 AT E479778 T1 ATE479778 T1 AT E479778T1 AT 05788285 T AT05788285 T AT 05788285T AT 05788285 T AT05788285 T AT 05788285T AT E479778 T1 ATE479778 T1 AT E479778T1
- Authority
- AT
- Austria
- Prior art keywords
- synthase activity
- small cell
- cell lung
- urlc8
- trna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/533—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving isomerase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/99—Isomerases (5.)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Pulmonology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61293704P | 2004-09-24 | 2004-09-24 | |
| PCT/JP2005/017915 WO2006033460A1 (en) | 2004-09-24 | 2005-09-21 | Method for diagnosing non-small cell lung cancers by trna-dihydrouridine synthase activity of urlc8 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE479778T1 true ATE479778T1 (de) | 2010-09-15 |
Family
ID=35559267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05788285T ATE479778T1 (de) | 2004-09-24 | 2005-09-21 | Verfahren zur diagnose nicht-kleinzelliger lungenkarzinome über die trna-dihydrouridin- synthaseaktivität von urlc8 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7897329B2 (de) |
| EP (3) | EP1799854B1 (de) |
| JP (1) | JP4908402B2 (de) |
| CN (1) | CN101061239B (de) |
| AT (1) | ATE479778T1 (de) |
| DE (1) | DE602005023329D1 (de) |
| WO (1) | WO2006033460A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010523081A (ja) * | 2007-03-30 | 2010-07-15 | オンコセラピー・サイエンス株式会社 | Cdca8−aurkb複合体を標的とするスクリーニング方法およびnsclcの治療方法 |
| US8512944B2 (en) | 2008-08-27 | 2013-08-20 | Oncotherapy Science, Inc. | PRMT1 for target genes of cancer therapy and diagnosis |
| CN102656281B (zh) | 2009-10-26 | 2016-04-20 | 雅培制药有限公司 | 用于测定非小细胞肺癌预后的诊断方法 |
| TW201122480A (en) * | 2009-10-26 | 2011-07-01 | Abbott Lab | Diagnostic methods for determining prognosis of non-small cell lung cancer |
| US20210198745A1 (en) * | 2016-02-05 | 2021-07-01 | Thoams Jefferson University | COMPOSITIONS AND METHODS OF USING HisGTG TRANSFER RNAS (tRNAs) |
| CN109337979A (zh) * | 2018-11-04 | 2019-02-15 | 华东医院 | tRNA相关肺腺癌预后模型及其应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US20020103360A1 (en) | 1998-09-01 | 2002-08-01 | Yang Pan | Novel protein related to melanoma-inhibiting protein and uses thereof |
| WO2000078954A2 (en) * | 1999-06-18 | 2000-12-28 | Incyte Genomics, Inc. | Human transcriptional regulator proteins |
| WO2001053312A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| US20030228618A1 (en) | 2000-11-24 | 2003-12-11 | Erez Levanon | Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same |
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| TW200413725A (en) * | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
| US20060024692A1 (en) | 2002-09-30 | 2006-02-02 | Oncotherapy Science, Inc. | Method for diagnosing non-small cell lung cancers |
| US20070224201A1 (en) * | 2002-10-02 | 2007-09-27 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
-
2005
- 2005-09-21 EP EP05788285A patent/EP1799854B1/de not_active Expired - Lifetime
- 2005-09-21 WO PCT/JP2005/017915 patent/WO2006033460A1/en not_active Ceased
- 2005-09-21 JP JP2007509810A patent/JP4908402B2/ja not_active Expired - Fee Related
- 2005-09-21 EP EP10178044A patent/EP2292753A1/de not_active Withdrawn
- 2005-09-21 CN CN2005800399082A patent/CN101061239B/zh not_active Expired - Fee Related
- 2005-09-21 EP EP09015324A patent/EP2163624A1/de not_active Withdrawn
- 2005-09-21 AT AT05788285T patent/ATE479778T1/de not_active IP Right Cessation
- 2005-09-21 US US11/575,812 patent/US7897329B2/en not_active Expired - Fee Related
- 2005-09-21 DE DE602005023329T patent/DE602005023329D1/de not_active Expired - Lifetime
-
2010
- 2010-05-18 US US12/782,641 patent/US20110014615A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20110014615A1 (en) | 2011-01-20 |
| EP2292753A1 (de) | 2011-03-09 |
| EP1799854B1 (de) | 2010-09-01 |
| JP4908402B2 (ja) | 2012-04-04 |
| CN101061239A (zh) | 2007-10-24 |
| EP2163624A1 (de) | 2010-03-17 |
| DE602005023329D1 (de) | 2010-10-14 |
| CN101061239B (zh) | 2011-08-17 |
| JP2008514186A (ja) | 2008-05-08 |
| EP1799854A1 (de) | 2007-06-27 |
| WO2006033460A1 (en) | 2006-03-30 |
| US20080119428A1 (en) | 2008-05-22 |
| US7897329B2 (en) | 2011-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005017781D1 (de) | Rekonstituierter histon-methyltransferase-komplex und verfahren zur identifizierung von modulatoren dafür | |
| ATE496142T1 (de) | Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs | |
| ATE533502T1 (de) | Verfahren zur modulation der il-23-aktivität; relevante reagenzien | |
| DK1734368T3 (da) | Annexin-autoantistoffer anvendt som markörer for lungecancer | |
| DE60325617D1 (de) | Verfahren zur diagnose von bauchspeicheldrüsenkrebs | |
| EP4293358A3 (de) | Flüchtige organische verbindungen als krebs biomarker | |
| DE60140865D1 (de) | Zusammensetzungen und methoden zur identifizierung von krebszellen | |
| DE602004019812D1 (de) | Marker für neuromyelitis optica | |
| ATE408828T1 (de) | Verfahren zur erkennung eines ovarialkarzinoms | |
| WO2004055519A3 (en) | Specific markers for pancreatic cancer | |
| DE602004015626D1 (de) | Bei brustkrebs | |
| ATE504836T1 (de) | Verfahren zur identifizierung von trpv2- modulatoren | |
| WO2003079020A3 (en) | Methods and compositions for the identification, assessment, and therapy of small cell lung cancer | |
| IL200120A0 (en) | Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes | |
| WO2005098445A3 (en) | Lung cancer biomarkers | |
| WO2020243021A3 (en) | Ntrk fusion molecules and uses thereof | |
| ATE397098T1 (de) | Verfahren zur diagnostik von eierstock endometriose | |
| ATE494548T1 (de) | Reinigung, charakterisierung und wiederherstellung einer ubiquitin-e3-ligase | |
| WO2009003706A3 (en) | Methods, kits, and compounds for determining responsiveness to treatment of a pathological disorder by epothilones | |
| EP2266628A3 (de) | Methode zur Bestimmung der Anfälligkeit für Knochenmetastasen über die Expression von EPhA2 | |
| ATE479898T1 (de) | Reagenzien und verfahren zur verwendung bei der diagnose, klassifizierung und behandlung von krebs | |
| ATE479778T1 (de) | Verfahren zur diagnose nicht-kleinzelliger lungenkarzinome über die trna-dihydrouridin- synthaseaktivität von urlc8 | |
| WO2004109286A3 (en) | Methods for detecting and treating cancer using podocalyxin and/or endoglycan | |
| WO2004113574A3 (en) | Methods for disease screening | |
| WO2007023191A3 (de) | Polypeptidmarker zur diagnose von blasenkrebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |